FDA reviews diabetic and HIV medications

The U.S. Food and Drug Administration has announced safety reviews of the FDA-approved medications Regranex Gel, Ziagen and Videx.

The FDA said study data suggests there might be an increased risk of death from cancer in diabetic patients using Regranex (becaplermin) Gel to treat leg and foot ulcers.

The FDA said it was also studying data that indicate a higher risk of heart attack in patients infected with the human immunodeficiency virus who take Ziagen (abacavir) or Videx (didanosine) as part of their drug therapy.

Until all three reviews are completed, the FDA said health care professionals should evaluate the potential risks and benefits of each drug with their patients.

Copyright 2008 by United Press International

Citation: FDA reviews diabetic and HIV medications (2008, March 27) retrieved 28 March 2024 from https://medicalxpress.com/news/2008-03-fda-diabetic-hiv-medications.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

New evidence on cervical cancer screening and treatment for women living with HIV

 shares

Feedback to editors